Skip to content

Company information lookup

ATCOR MEDICAL HOLDINGS LIMITED (ACG)

The development and marketing of the SphygmoCor device used for cardiovascular patient assessment and management.

On this page you will find:

Company snapshot
Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
ACG 0.120 4.35% 0.120 0.125 0.120 0.120 0.115 128,300

ATCOR MEDICAL HOLDINGS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code ACG
Securities
Official Listing Date 9 November, 2005
GICS Industry Group Health Care Equipment & Services
Exempt Foreign? No
Internet Address http://www.atcormedical.com.au/
Registered Office Address Suite 11, 1059-1063 Victoria Road, WEST RYDE, NSW, AUSTRALIA, 2114
Head Office Telephone (02) 9874 8761
Head Office Fax (02) 9874 9022
Share Registry LINK MARKET SERVICES LIMITED
LEVEL 12, 680 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone 1300 554 474
Directors / Senior Management
Mr Donal O'Dwyer (Non Exec. Chairman)
Mr Duncan Ross (CEO)
Dr David Brookes (Non Exec. Director)
Mr Peter Jenkins (Non Exec. Director)
Dr Michael O'Rourke (Non Exec. Director)
Mr Peter Manley (CFO)
Company Secretary Mr Peter Manley
Principal Activities The development and marketing of the SphygmoCor device used for cardiovascular patient assessment and management.

ATCOR MEDICAL HOLDINGS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
16/04/2014 asterix Patent grant in USA 1 PDF
03/04/2014 asterix Study shows improved outcomes from SphygmoCor guided therapy 2 PDF
07/03/2014   Change in substantial holding 4 PDF
20/02/2014   1H FY2014 results 2 PDF
20/02/2014 asterix Half Yearly Report and Accounts 17 PDF
30/01/2014 asterix SphygmoCor XCEL approved for sale in Canada 1 PDF
14/01/2014   Ceasing to be a substantial holder from ALF 1 PDF
14/01/2014 asterix SphygmoCor XCEL approved for sale in China 1 PDF
09/01/2014 asterix Market update 2 PDF
08/01/2014   Appendix 3B 13 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
17 Apr 2014 0.120 4.35% 0.120 0.115 128,300
16 Apr 2014 0.115 4.55% 0.120 0.110 175,092
15 Apr 2014 0.110 0% 0.110 0.110 28,765
14 Apr 2014 0.110 0% 0.110 0.110 14,817
11 Apr 2014 0.110 -12% 0.120 0.110 372,079

* Volume of shares shown represents only those shares traded on ASX.

ATCOR MEDICAL HOLDINGS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security ACG. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security ACG

Warrants & Structured Products

No warrants & Structured Products are available over the security ACG

ASX CFDs

No Contracts For Differences are available over the security ACG